id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
743680,9d7e8c3d-2b56-4810-8499-012c982b3214,3A,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2009,third_quarter,PHA,"H.R. 822, H.R. 1943, H.R. 6114, S-2969",,75000,,0,0,2009-02-10T20:06:50-05:00
743681,c15a1a3d-82cb-416d-ab9d-0ae3f39c4b25,1A,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2009,first_quarter,PHA,"H.R. 822, H.R. 1943, H.R. 6114, S-2969",,75000,,0,0,2009-02-10T20:08:50-05:00
743682,e3fa9c29-7b9e-419f-a67a-d5beb5a109b0,2A,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2009,second_quarter,PHA,"H.R. 822, H.R. 1943, H.R. 6114, S-2969",,75000,,0,0,2009-02-10T20:11:51-05:00
743916,d855cceb-2420-4dd5-a47a-c5ad3c3be488,Q1,HOLLAND & KNIGHT LLP,18466,AMERICAN SOCIETY OF HEMATOLOGY,2009,first_quarter,PHA,Hematology and Oncology drug research and approval issues.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2009-03-25T11:34:28-04:00
743925,e44a52a6-a84a-4014-89b6-d0db2d3e6f52,Q1,HOLLAND & KNIGHT LLP,18466,NATIONAL HEMOPHILIA FOUNDATION,2009,first_quarter,PHA,Blood and blood product safety; issues related to blood product approvals.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",40000,,0,0,2009-03-25T12:04:34-04:00
744097,ff534b94-18e2-482a-b838-7cc13e03433f,Q1,"CYBER SECURITY RESEARCH CONSULTANTS, LLC",91694,PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2009,first_quarter,PHA,"Food and Drug Safety Globalization Act
Monitoring Dorgan-Snowe drug reimportation from Canada","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2009-03-31T19:49:29-04:00
744289,15ef8fc3-fada-496c-afce-ab342b928afb,Q1,HOLLAND & KNIGHT LLP,18466,BIOTECHNOLOGY INDUSTRY ORGANIZATION,2009,first_quarter,PHA,Issues relating to the biotechnology industry.,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2009-04-02T09:45:10-04:00
745724,86ba574c-8de6-4954-83db-abc82765e3cd,Q1,SQUIRE PATTON BOGGS,30906,KERR CORPORATION,2009,first_quarter,PHA,FDA enforcement action against counterfeits of client's medical devices.,HOUSE OF REPRESENTATIVES,10000,,0,0,2009-04-08T11:52:47-04:00
746341,34e3f6de-d8a6-40f1-96f1-09202886c1fb,Q1,"EXPRESS SCRIPTS, INC.",294416,"EXPRESS SCRIPTS, INC.",2009,first_quarter,PHA,"Items related to reverse settlement payments between manufacturers, H.R. 1706","Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE",,250000,0,0,2009-04-09T15:04:12-04:00
746618,d3e63136-0483-4ac3-b600-988833d4688c,Q1,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2009,first_quarter,PHA,General issues affecting the pharmaceutical industry.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2009-04-10T10:43:47-04:00
746675,483b42ca-fec1-4a9e-80ac-3fdcb1d4375a,Q1,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2009,first_quarter,PHA,"Average Manufacturers Price Pharmacy Reimbursement
S. 511 and H.R. 616 Preserve Patient Access DMEPOS Accreditation","HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2009-04-10T11:26:49-04:00
746879,a48fe2ad-d8f8-472d-b47c-4c4eb7e38306,Q1,"DUTKO WORLDWIDE, LLC",12868,IBIS BIOSCIENCES,2009,first_quarter,PHA,Counsel and advise client regarding attempts to secure federal procurement contracts for biosensor device.,"Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",10000,,0,0,2009-04-10T14:54:07-04:00
746949,594a3772-fbf0-4897-8e1b-b1382e3a5ccd,Q1,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2009,first_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510).","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2009-04-10T15:42:43-04:00
747087,da94379d-14fa-4738-8165-5a45104159d4,Q1,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,"JOHNSON & JOHNSON SERVICES, INC.",2009,first_quarter,PHA,"Follow-on Biologics
FDA medical device approval
Cancer screening
Pre-emption; legal reform","HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2009-04-10T18:09:30-04:00
747617,19240150-60dd-4682-a076-7fd6881947e5,Q1,WINBORN SOLUTIONS LLC,308310,PERRIGO CO,2009,first_quarter,PHA,"Dextromethorphan Distribution Act of 2009
Food and drug safety, user fee, and country of origin legislation","HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2009-04-13T10:18:01-04:00
747673,4ecb3ed0-7df6-43b0-bc9f-29da3f64b485,Q1,POLICY ADVOCATES,72018,PHOENIX CAPITAL MANAGEMENT LLC,2009,first_quarter,PHA,Track and monitor Internet Pharmacy Issues.,"HOUSE OF REPRESENTATIVES,SENATE",7500,,0,0,2009-04-13T10:57:25-04:00
747823,a8698a09-54b0-42bd-ba07-02cdd57b816b,Q1,ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,58534,ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,2009,first_quarter,PHA,"H.R. 444; H1 To amend section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers, any language expanding 340B drug discounts to inpatient settings.","HOUSE OF REPRESENTATIVES,SENATE",,41044,0,0,2009-04-13T12:22:02-04:00
748132,f8668df5-c3c1-4c35-8fcc-93bc0102971a,Q1,MR. THEODORE (TED) JONES,20926,PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA,2009,first_quarter,PHA,Trade Association for certain Pharmaceutical Companies,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2009-04-13T16:39:11-04:00
748223,2c5af353-8c34-497b-8401-288998789f5a,1T,"CGCN GROUP, LLC",76992,BARR PHARMACEUTICALS INC (FORMERLY BARR LABORATORIES INC ),2009,first_quarter,PHA,"H.R. 3161, S. 1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act.  H.R. 2900, S. 1082, Food and Drug Administration Reform.","HOUSE OF REPRESENTATIVES,SENATE",6500,,0,1,2009-04-13T21:42:57-04:00
748521,08e73a0a-4a5a-4443-b6b2-499dfdfaaddb,Q1,MICHAEL POLLARD,87836,MEDCO HEALTH SOLUTIONS INC,2009,first_quarter,PHA,"HR 1204--Community Pharmacy Fairness Act of 2009; all sections
S. 525---Pharmaceutical Market Access and Drug Safety Act of 2009; all aspects","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2009-04-14T11:37:30-04:00
748590,692dd5d3-0032-4107-94b0-b480c6e4da0e,1A,HOLLAND & KNIGHT LLP,18466,BIOTECHNOLOGY INDUSTRY ORGANIZATION,2009,first_quarter,PHA,Issues relating to the biotechnology industry.,"HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2009-04-14T12:11:51-04:00
748685,f5f4490c-39ed-4794-be9c-cd2bb7273e29,Q1,KIRKLAND & ELLIS LLP,21745,TEVA PHARMACEUTICALS USA,2009,first_quarter,PHA,House and Senate legislation on biologic medicines.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2009-04-14T13:00:18-04:00
748859,a8424dce-b878-4c92-82f8-acb95343f574,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AMERICAN ASSOCIATION FOR HEALTH FREEDOM,2009,first_quarter,PHA,Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2009-04-14T14:59:05-04:00
749607,442f72ae-1735-46ff-895a-6eff5a64bc12,Q1,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2009,first_quarter,PHA,"H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs.
H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan.
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals.
S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs.
H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs.
H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs.
H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements.
The Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
Various issues related to the role of pharmacy and pharmacists in healthcare reform, including pharmacy services in the Medicare program.","Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,White House Office",,440000,0,0,2009-04-15T10:23:03-04:00
749741,21a67052-bd39-489b-b0b3-4ecfdaee6e17,Q1,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2009,first_quarter,PHA,Controlled Drug Substances Act (21 USC 13),"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2009-04-15T11:01:58-04:00
750165,689a01c6-c209-4f61-b166-62c51e495e57,Q1,"MOFFETT GROUP, LLC",82578,BOEHRINGER INGELHEIM PHARMECEUTICAL,2009,first_quarter,PHA,"Phamaceutical issues, especially with respect to the House Energy and Commerce Committee.","HOUSE OF REPRESENTATIVES,SENATE",25000,,0,0,2009-04-15T12:35:32-04:00
750440,09fe7193-6bcf-43ef-bb5b-8f9e3cd611a6,1T,CAPITOL HILL CONSULTING GROUP,72053,DFB PHARMACEUTICALS INC,2009,first_quarter,PHA,General Pharmaceutical Issues pertaining to the company. No specific legislation,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,1,2009-04-15T13:49:33-04:00
750829,5c36a9f6-e520-46e8-bf82-8af1ef0f5e87,Q1,UPS (UNITED PARCEL SERVICE),39223,UPS (UNITED PARCEL SERVICE),2009,first_quarter,PHA,UPS Supply Chain Solutions Healthcare Issues,"Federal Aviation Administration (FAA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Trade Representative (USTR),White House Office",,1316426,0,0,2009-04-15T15:38:18-04:00
750872,4bbd70b2-80d5-45b0-809c-16ed766f6b5a,Q1,FOLEY & LARDNER LLP,15042,UNITED THERAPEUTICS,2009,first_quarter,PHA,Approval and funding for development and application of broad spectrum antiviral drugs,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2009-04-15T15:44:06-04:00
750886,53f2fdd9-1447-4845-aa24-a74a8a6a0ebd,Q1,POLICY DIRECTIONS INC.,31747,ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ),2009,first_quarter,PHA,"Antibiotics in animal foods
Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine.

S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA.

Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling.

Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act.

Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds.","Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2009-04-15T15:46:36-04:00
751713,841fde19-630c-48cb-aa1a-9793a5b9f82d,Q1,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF CONNECTICUT,2009,first_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues.
Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2009-04-16T07:46:30-04:00
751857,ad276031-df32-4c22-a082-5aaed1c4a268,Q1,LATHAM & WATKINS LLP,22201,AMPHASTAR PHARMACEUTICALS,2009,first_quarter,PHA,"Congressional oversight of the Food and Drug Administration and Environmental Protection Agency
EPA rulemaking on CFC propellants","Environmental Protection Agency (EPA),Food & Drug Administration (FDA)",10000,,0,0,2009-04-16T09:41:17-04:00
751879,f2b24998-0748-400f-92ea-e6afcc6ff068,Q1,LATHAM & WATKINS LLP,22201,ORCHID CHEMICALS & PHARMACEUTICALS LTD,2009,first_quarter,PHA,Food and Drug Administration policy.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2009-04-16T09:49:24-04:00
751887,59a843e1-49d0-4cde-8f3f-40c96df6cf3b,Q1,SQUIRE PATTON BOGGS,30906,SUNOVION PHARMACEUTICALS INC,2009,first_quarter,PHA,"Issues related to inhalation drugs, including Xopenex.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2009-04-16T09:52:42-04:00
752013,7d52b1d5-d89e-4689-8238-04fe9a9e9ae3,Q1,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2009,first_quarter,PHA,"Importation of prescription drugs (S. 525/H.R. 1298); Import Safety (H.R. 759);
Rx Pedigree; Counterfeit Drugs (H.R. 1450);
Methamphetamine/Pseudoephedrine Regulation (S. 256);
Dextromethorphan Regulation (H.R. 1259)","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,220000,0,0,2009-04-16T10:24:07-04:00
752581,d6b0e93a-9376-4ce8-acc2-37c89928c67d,Q1,UNIVERSITY OF CONNECTICUT,39382,UNIVERSITY OF CONNECTICUT,2009,first_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues.
Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,70000,0,0,2009-04-16T12:21:10-04:00
752798,0c410513-24af-437e-b138-03ca35275613,Q1,"APTIV, PLC",49054,APTIV PLC,2009,first_quarter,PHA,"Accessibility of generic drugs
e-prescriptions
Medical IT","Commerce, Dept of (DOC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Federal Aviation Administration (FAA),Federal Motor Carrier Safety Administration,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),Pension Benefit Guaranty Corporation (PBGC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA)",,420000,0,0,2009-04-16T13:01:17-04:00
752818,f3f549fc-61ed-4189-b873-1d04e4f5c6a5,Q1,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",4653,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",2009,first_quarter,PHA,"Proposals to place a moratorium on prescription drug advertising and requiring a ""fair balance"" between risk and benefit information in prescription drug advertisements
Proposals to extend FDA authority to over-the-counter drug advertisements","Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,230000,0,0,2009-04-16T13:03:25-04:00
752939,c8e14127-01b5-412d-bb98-c6270e19e81f,Q1,"FLYNN & ASSOCIATES, INC.",15020,PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION,2009,first_quarter,PHA,"State Childrens Health Insurance Program
Patent Reform Legislation
Pharmaceutical industry employment issues","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2009-04-16T13:39:16-04:00
753341,e3542640-e726-4343-8c47-db6b637728d5,Q1,MASSACHUSETTS MEDICAL SOCIETY,23975,MASSACHUSETTS MEDICAL SOCIETY,2009,first_quarter,PHA,"Biologicals  legislation to establish standards for the FDA approval of biologically equivalent drugs (no contact  no legislation)
S. 301, Physician Payment Sunshine Act  legislation which would require pharmaceutical companies and device manufactures to disclosure gifts and other contributions to physicians","Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2009-04-16T14:28:49-04:00
753477,0de3b613-9087-4c88-a5ab-00ecf84b74fb,Q1,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,MERCK & CO,2009,first_quarter,PHA,Congressional oversight relating to Vioxx and Vytorin and matters relating to healthcare reform.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2009-04-16T14:48:42-04:00
753482,ca799938-68dc-4df2-babf-d91889bac0b3,Q1,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2009,first_quarter,PHA,Communication seeking withdrawal of propxyphene from the market. Communication re: experimental study of consumer reporting of side effects as part of direct-to-consumer advertising.  Communication re: evaluation and usefulness of consumer medication information. Communication re: FDA's Sentinal Initiative to monitor medical product safety.  Comments on disposal of controlled substances.,"Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,250000,0,0,2009-04-16T14:49:44-04:00
753622,b5cade5a-aebd-4797-a0af-c886438a7980,Q1,AMERICAN VETERINARY MEDICAL ASSOCIATION,3630,AMERICAN VETERINARY MEDICAL ASSOCIATION,2009,first_quarter,PHA,"HR 1549/S 619, Preservation of Antibiotics for Medical Treatment Act","Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,170000,0,0,2009-04-16T15:04:30-04:00
753718,33ce6c47-04bd-49ff-8ff4-438ea8ee25f9,Q1,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF MARYLAND BALTIMORE,2009,first_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2009-04-16T15:14:11-04:00
753804,a412a977-91dd-46b4-9aa5-0b0b081a743f,Q1,DUANE MORRIS GOVERNMENT AFFAIRS,49657,CB DISTRIBUTORS INC,2009,first_quarter,PHA,Regulation of over-the-counter asthma-cough medicines.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2009-04-16T15:28:43-04:00
753831,141998fc-0ab7-4c25-9ebe-3e7159298052,Q1,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE,2009,first_quarter,PHA,"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA and USDA funding initiatives.
Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA and USDA funding initiatives.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2009-04-16T15:32:58-04:00
753842,f802f154-6f00-4946-ab67-860823c86238,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2009,first_quarter,PHA,Coverage for direct patient care services of qualified pharmacists under Medicare Part B.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,61950,0,0,2009-04-16T15:34:05-04:00
753969,6adb1bc4-ac51-481a-a743-3503e833766e,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2009,first_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2009-04-16T15:49:57-04:00
754045,7173b0e0-9ba3-48d1-8f5e-245f83a0f164,Q1,OGR,48827,SANOFI PASTEUR,2009,first_quarter,PHA,vaccine related issues,HOUSE OF REPRESENTATIVES,20000,,0,0,2009-04-16T15:58:27-04:00
754411,7c5a6c87-4ca1-4d24-be4b-5012e093ba40,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,INTL ACADEMY OF COMPOUNDING PHARMACISTS,2009,first_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2009-04-16T17:05:27-04:00
754880,58a36742-89cd-4fad-b12f-f3d9a61337e9,Q1,WINSTON & STRAWN LLP,41682,FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ),2009,first_quarter,PHA,Represent the client on issues related to assuring a safe supply of heparin.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2009-04-16T19:55:56-04:00
755164,093df4a1-fd2d-4b1c-b5c9-61cc28aea0a8,Q1,EISAI INC.,400321512,EISAI INC.,2009,first_quarter,PHA,"HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act
HR 1548, Pathway for Biosimilars Act of 2009
S. 726, Promoting Innovation and Access to Life-Saving Medicine Act","HOUSE OF REPRESENTATIVES,SENATE",,620000,0,0,2009-04-17T09:55:05-04:00
755601,eb04e1a3-f24f-42b7-b79f-147948f96bbd,Q1,ANIMAL HEALTH INSTITUTE,4037,ANIMAL HEALTH INSTITUTE,2009,first_quarter,PHA,"Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act","HOUSE OF REPRESENTATIVES,SENATE",,25000,0,0,2009-04-17T11:00:34-04:00
755659,8db204cc-4b4d-44ad-9039-41c5826199e4,Q1,BLUE CROSS BLUE SHIELD OF MICHIGAN,46676,BLUE CROSS BLUE SHIELD OF MICHIGAN,2009,first_quarter,PHA,"Biogenerics/Generic Biologics:  HR1427 ""Promoting Innovation and Access to Life-Saving Medicine Act""","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2009-04-17T11:07:42-04:00
755849,d41c25ed-f594-4bc6-a5a2-b87f89d2fbe2,Q1,GEPHARDT GROUP GOVERNMENT AFFAIRS,315717,THE MEDICINES COMPANY,2009,first_quarter,PHA,patent issue,"HOUSE OF REPRESENTATIVES,SENATE",250000,,0,0,2009-04-17T11:25:55-04:00
755957,0aa7ee5b-d900-4454-bbf2-6acffeff6609,1T,BROYDRICK & ASSOCIATES,7268,BARR LABORATORIES,2009,first_quarter,PHA,"Patent reform, Generic Biologies","HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2009-04-17T11:40:12-04:00
756032,90069468-7d88-48aa-820f-a04286ff11fa,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2009,first_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2009-04-17T11:45:16-04:00
756188,d0f0b59a-fffb-4ec1-b304-9cb3a98a6e42,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2009,first_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2009-04-17T12:00:28-04:00
756200,35b0d85f-c87d-4b9b-a67b-094321612718,Q1,"VAN NESS FELDMAN, LLP",39815,MCKESSON CORPORATION,2009,first_quarter,PHA,"S. 256, Combat Methamphetamine Enhancement Act of 2009
S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2009-04-17T12:01:38-04:00
756219,834ede01-7433-405a-b09e-ebfbe97091c8,Q1,FABIANI & COMPANY,72576,"ACORDA THERAPEUTICS, INC.",2009,first_quarter,PHA,"Educate members and staff about Acordas products.
Secure funding through the annual appropriation process for research.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2009-04-17T12:02:43-04:00
756366,68ce1eba-39a1-4701-8286-1d8d1d5833fe,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2009,first_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2009-04-17T12:13:36-04:00
756391,d2a68dd2-37f7-434b-a489-87b55473e1ec,Q1,THE UNITED STATES PHARMACOPEIAL CONVENTION,400358632,THE UNITED STATES PHARMACOPEIAL CONVENTION,2009,first_quarter,PHA,"-GAO Study on Dietary Supplement Regulation, provided comments for.
-HR 759 ""The Food and Drug Administration Globalization Act of 2009"", regarding provisions on drugs and food ingredients with specific reference to drug quality, food quality and compendial modernization.
-Letter to DHHS Secretary Designate regarding FDA Mission on drug quality, food quality, standards and follow-on biologics. -Letter to Acting Commissioner of FDA regarding FDA budget and standards.
-Communication with Congress on standards of use for heparin and glycerin.
-Communication with FDA regarding drug quality, food quality and follow-on biologics and FDA resources.
-Letter to Congress on legislative issues before Congress regarding drug quality, food quality and follow-on biologics and FDA resources.
-Provided information to Congress for a hearing on drug issues regarding intellectual property issues for drugs.
-HR 1298 ""Pharmaceutical Market Access & Drug Safety Act of 2009"", regarding all provisions on the effect of re-importation provisions on FDA requirements and USP Compendial Standards for Drugs.
-Letter to FDA Commissioner-Designate regarding FDA resources, drug quality and food quality.
-HR 1427 / S 726 ""Promoting Innovation and Access to Lifesaving Medicine Act"", regarding all provisions on biologics; role and importance of standards, follow-on biologics.
-HR 1548 ""Pathway for Biosimilars Act"", regarding all provisions on biologics; role of importance of standards, follow-on biologics.
-HR 1105 ""FY 2009 Omnibus Appropriations Act"", regarding provisions on verification programs, standards and resources for FDA.","Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE",,100000,0,0,2009-04-17T12:18:28-04:00
756414,9410a679-f763-4832-8f42-4f1c26ade683,Q1,"BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.",323876,BLUE CROSS AND BLUE SHIELD OF KANSAS INC,2009,first_quarter,PHA,"Biogenerics/Generic Biologics: HR1427 ""Promoting Innovation and Access to Life-Saving Medicine Act""","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2009-04-17T12:20:53-04:00
756604,67f6d0f4-a4e4-47c5-a11d-7b6e49394d0b,Q1,"THE OB-C GROUP, LLC",29802,ELI LILLY,2009,first_quarter,PHA,"HR 1548, Pathway for Biosimilars Act; entire bill.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2009-04-17T12:41:59-04:00
756756,8c893a3c-af3b-4759-a29a-5e890c8df6cb,Q1,APOTEX CORP.,310973,APOTEX CORP.,2009,first_quarter,PHA,"S. 369, the Preserve Access to Affordable Generics Act
HR 1706, the Protecting Consumer Access to Generic Drugs Act 
HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act
S. 726, the Promoting Innovation and Access to Life Saving Medicine Act HR 1548, Pathway for Biosimilars Act
S. 501, the Fair Prescription Drug Competition Act
HR 573 concerning authorized generics","Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2009-04-17T13:00:41-04:00
756806,007eef46-69ad-4ed8-925e-0cf73ef85232,Q1,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2009,first_quarter,PHA,"Increased appropriations for systems to shorten the time between development of a drug and its release to the public.
FDA reform as it relates to drug development and research
Collaborative research on drug development                                 anti-malarial pharmaceuticals
FY2009 and FY 2010 Agricultural Appropriations                       human factors research related to neuropharmaceuticals","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,110000,0,0,2009-04-17T13:03:00-04:00
756914,7cd260b9-a665-486c-8733-1c597c97c49c,Q1,"EVERGREEN ASSOCIATES, LTD.",13984,PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION,2009,first_quarter,PHA,"Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts",Food & Drug Administration (FDA),,,0,0,2009-04-17T13:14:55-04:00
757162,aef3b341-0b2f-4a12-bb5b-5d9ef1facc77,Q1,FABIANI & COMPANY,72576,ALNYLAM PHARMACEUTICALS,2009,first_quarter,PHA,"S.515 Patent Reform Act
Provisions relating to the apportionment of damages","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2009-04-17T13:54:22-04:00
757172,8fedc1fd-402b-48d3-bbbf-5fa31a832408,Q1,DUANE MORRIS GOVERNMENT AFFAIRS,49657,LEHIGH VALLEY TECHNOLOGIES,2009,first_quarter,PHA,Monitor Federal activity relating to pharmaceutical manufacturing.,"Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2009-04-17T13:55:23-04:00
757474,92daf5ef-2af7-4b84-9803-61c47b238b83,Q1,FABIANI & COMPANY,72576,VAXINNATE,2009,first_quarter,PHA,"Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development","Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2009-04-17T14:21:11-04:00
757507,47622a39-6c4d-485a-8a9d-4b740837528f,Q1,JOHNS HOPKINS UNIVERSITY,20664,JOHNS HOPKINS UNIVERSITY,2009,first_quarter,PHA,"H.R. 444, 340B Program Improvement and Integrity Act of 2009. Issues regarding extending 340B outpatient pharmaceutical discount to the inpatient setting.","HOUSE OF REPRESENTATIVES,SENATE",,190000,0,0,2009-04-17T14:22:27-04:00
757565,29c35e66-7f8d-4461-a383-4c23b0342141,Q1,"GENENTECH, INC",15920,GENENTECH INC,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act of 2009
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,700000,0,0,2009-04-17T14:25:44-04:00
758242,115e1d30-863e-4828-9225-c465c726f81b,Q1,FOLEY HOAG LLP,79610,GLAXOSMITHKLINE,2009,first_quarter,PHA,Drug Safety; Prevention and Chronic Disease Management,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2009-04-17T15:20:37-04:00
758266,b629af99-4ede-4daf-8926-eec746931704,Q1,INDEPENDENCE BLUE CROSS,19172,INDEPENDENCE BLUE CROSS,2009,first_quarter,PHA,"Biogenerics/Generic  Biologics: HR1427 ""Promoting Innovation and  Access to Life-Saving Medicine Act""","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,,0,0,2009-04-17T15:21:40-04:00
758322,01614ff3-4302-4417-b07f-1ece3904074a,Q1,US STRATEGIES,38825,NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT),2009,first_quarter,PHA,Medicare and Medicaid provisions relating to pharmacy and medication management policies,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2009-04-17T15:23:53-04:00
758583,cdea555a-7045-435b-b2c8-dd8096bc4485,Q1,ALCALDE & FAY,818,"XSTREAM SYSTEMS, INC.",2009,first_quarter,PHA,"Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA)",20000,,0,0,2009-04-17T15:40:38-04:00
758631,a119b6ec-b3b3-4a0f-aa42-1aa0b1ee0822,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ),2009,first_quarter,PHA,No specific legislation or bills introduced at this time.  Medicare reimbursement issues.,"HOUSE OF REPRESENTATIVES,SENATE",55000,,0,0,2009-04-17T15:42:50-04:00
758815,afcea7b3-db60-4900-9460-081a7451caea,Q1,"BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.",6382,BLUE CROSS AND BLUE SHIELD OF FLORIDA INC,2009,first_quarter,PHA,"Biogenerica/Generic Biologics:  H.R.1427 ""Promoting Innovation and Access to Life-Saving Medicine Act""","HOUSE OF REPRESENTATIVES,SENATE",,320000,0,0,2009-04-17T16:00:22-04:00
758831,61ae7415-2ea1-459f-b1a8-a740351049d9,Q1,"MEDCO HEALTH SOLUTIONS, INC",89177,MEDCO HEALTH SOLUTIONS INC,2009,first_quarter,PHA,"Electronic Prescribing, Mail Order Pharmacy HR 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,990000000,0,0,2009-04-17T16:01:09-04:00
758833,e0d46e59-b562-436f-af46-22df3e59b128,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION,2009,first_quarter,PHA,Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2009-04-17T16:01:24-04:00
758997,05006b54-c277-445a-a8f9-4c9a26974303,Q1,KNIGHT CAPITOL CONSULTANTS,40036301,"SANOFI US SERVICES INC (FORMERLY KNOWN AS ""SANOFI-AVENTIS U S INC )",2009,first_quarter,PHA,Monitor general issues of interest to pharmaceutical industry (no specific bills),"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2009-04-17T16:17:01-04:00
759155,189f5dc8-f0ca-4f02-acb8-16fdcb4f3323,Q1,BLUECROSS BLUESHIELD OF TENNESSEE,6440,BLUECROSS BLUESHIELD OF TENNESSEE,2009,first_quarter,PHA,"Biologicals S.623
E-Prescribing - Enhanced Health Care Value for All Act
 Comparative Effectiveness Research Act","HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2009-04-17T16:27:34-04:00
759180,05cc7365-91e9-4c77-b24a-8147365f6bcc,Q1,AMYLIN PHARMACEUTICALS,308536,AMYLIN PHARMACEUTICALS,2009,first_quarter,PHA,"S. 301, Physician Payments Sunshine Act of 2009
H.R. 1548, Pathway for Biosimilars Act
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act
S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety
H.R. 759, Food and Drug Administration Globalization Act of 2009","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,350000,0,0,2009-04-17T16:29:46-04:00
759247,f8014bec-1a9f-405a-9508-6ba92b683cb7,Q1,AARP,1694,AARP,2009,first_quarter,PHA,"S.525/H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad.
S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs.
H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes.
S.515/H.R.1260, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability.  Specifically, AARP weighed in on the inequitable conduct provisions of the legislation.
S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians.","Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Reserve System,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office",,4080000,0,0,2009-04-17T16:34:40-04:00
759391,e0af7e22-ba69-4c6a-8450-c3f6efe6f1b1,Q1,BUCHANAN INGERSOLL & ROONEY PC,55291,BIOFACTURA,2009,first_quarter,PHA,"Biotechnology, Disaster Planning, Homeland Security, Science & Technology and Pharmacy issues with the US House, US Senate and Federal Agencies","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2009-04-17T16:51:10-04:00
759884,91e7f92b-4092-451a-a8bf-bc16ff1a22fc,Q1,UNIVERSITY OF KANSAS,321373,UNIVERSITY OF KANSAS,2009,first_quarter,PHA,Contacted congressional delegation regarding multi-university pharmaceutical research consortium,"Army, Dept of (Other),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Securities & Exchange Commission (SEC),SENATE",,172000,0,0,2009-04-17T18:18:07-04:00
760792,3bb866a5-f3f3-4fbd-ad84-1b03f283a732,Q1,"PODESTA GROUP, INC.",31680,BRISTOL-MYERS SQUIBB,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathyway for Biosimilars Act
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Drug Importation/Drug Safety","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2009-04-19T06:24:42-04:00
760798,0c527686-fe05-40fd-8e2c-ee987fe7c735,Q1,"PODESTA GROUP, INC.",31680,CUBIST PHARMACEUTICALS INC,2009,first_quarter,PHA,"Medical Research
Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues
Antibiotic Resistance issues","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2009-04-19T06:40:45-04:00
760802,55f08704-b0a6-40b5-bfc6-34abb95c8365,Q1,"PODESTA GROUP, INC.",31680,WINNING STRATEGIES WASHINGTON LLC,2009,first_quarter,PHA,"Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2009-04-19T06:47:47-04:00
760808,4314531e-bcca-4a90-a803-1ffff86c1fe9,Q1,"PODESTA GROUP, INC.",31680,EISAI INC.,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2009-04-19T06:52:50-04:00
760814,b7793f59-882d-4b71-a9ee-2702c8b8057c,Q1,"PODESTA GROUP, INC.",31680,EMD SERONO INC,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Drug importation","HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",60000,,0,0,2009-04-19T06:58:51-04:00
760824,0b93179d-a682-4166-a64f-d7f7558fdddf,Q1,"PODESTA GROUP, INC.",31680,GENENTECH,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act of 2009
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2009-04-19T07:01:55-04:00
760835,770912b7-da49-42a4-b2fb-26b6bb5a91c1,Q1,"PODESTA GROUP, INC.",31680,GENZYME,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Neglected Disease Issues","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",130000,,0,0,2009-04-19T07:21:01-04:00
760844,0bf5d49b-3182-4183-87ee-398369a5b8e9,Q1,"PODESTA GROUP, INC.",31680,THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER,2009,first_quarter,PHA,"Patient safety, animal research, clinical trials, scientific misconduct, conflict of interest","HOUSE OF REPRESENTATIVES,SENATE",110000,,0,0,2009-04-19T08:18:28-04:00
760853,ab9268a8-c3b7-49f6-a23f-8a5a6e65251c,Q1,"PODESTA GROUP, INC.",31680,MILLENNIUM PHARMACEUTICALS INC,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine
H.R. 1548 Pathway for Biosimilars Act
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2009-04-19T08:25:32-04:00
760869,aa873348-60f8-4128-97db-846a4e2d1be0,Q1,"PODESTA GROUP, INC.",31680,NOVO NORDISK INC,2009,first_quarter,PHA,"H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine
H.R. 1548 Pathway for Biosimilars Act
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",60000,,0,0,2009-04-19T08:46:44-04:00
760928,0f65a6e7-34a8-4c95-be42-9c81df4f208d,Q1,WALMART INC.,40305,WALMART INC,2009,first_quarter,PHA,"H.R. 1548 & S. 1427, Legislation amending title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes  Average Manufacturers Price","Consumer Product Safety Commission (CPSC),Council on Environmental Quality (CEQ),Energy, Dept of,Federal Energy Regulatory Commission (FERC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Natl Drug Control Policy (NDCP),SENATE,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office",,1522308,0,0,2009-04-19T10:22:53-04:00
761264,72beb5da-b26a-425c-8c7f-05ab95ff1d05,1T,"RUBICON ADVISORS, LLC",315091,AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS,2009,first_quarter,PHA,"Healthcare: Medicare Reimbursement, Centers for Medicare & Medicaid Services",,30000,,0,1,2009-04-19T15:52:03-04:00
761273,1b9ae847-fdb1-407d-b345-88e9b406613f,Q1,SHIRE PHARMACEUTICALS LLC,323477,SHIRE PHARMACEUTICALS LLC,2009,first_quarter,PHA,"H.R. 1548, Pathway for Biosimilars Act, provisions relating to ultra-orphan biologics.
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, provisions relating to ultra-orphan biologics.","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2009-04-19T15:54:06-04:00
761275,e7de48d7-f93d-4301-934c-40dccb4ce80b,Q1,"RUBICON ADVISORS, LLC",315091,"BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.",2009,first_quarter,PHA,"Physician Payment Sunshine Act S. 2029
Patent Settlements H.R. 1432S. 316",,30000,,0,0,2009-04-19T15:55:07-04:00